Pharmacology of Modality-Specific Transient Receptor Potential Vanilloid-1 Antagonists That Do Not Alter Body TemperatureJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82012-08-0180PREAI
The effect of aging on the density of the sensory nerve fiber innervation of bone and acute skeletal painNEUROBIOLOGY OF AGINGIF3.52012-05-0149OAAI
Pathophysiology and medical treatment of pain in fibrous dysplasia of boneORPHANET JOURNAL OF RARE DISEASESIF3.52012-01-0185OAAI
Preventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation, and cancer painPAINIF5.52011-11-01155OAAI
Breast Cancer-Induced Bone Remodeling, Skeletal Pain, and Sprouting of Sensory Nerve FibersJOURNAL OF PAINIF42011-06-01161OAAI
Sustained blockade of neurotrophin receptors TrkA, TrkB and TrkC reduces non-malignant skeletal pain but not the maintenance of sensory and sympathetic nerve fibersBONEIF3.62011-02-0173OAAI
Effects of a monoclonal antibody raised against nerve growth factor on skeletal pain and bone healing after fracture of the C57BL/6J mouse femurJOURNAL OF BONE AND MINERAL RESEARCHIF5.92009-12-04107OAAI
Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermiaPAINIF5.52009-03-01131PRE
Intravenous ibandronate rapidly reduces pain, neurochemical indices of central sensitization, tumor burden, and skeletal destruction in a mouse model of bone cancerJOURNAL OF PAIN AND SYMPTOM MANAGEMENTIF3.52008-09-0118OAAI
Fracture pain model in the rat: Adaptation of a closed femur fracture model to study skeletal painANESTHESIOLOGYIF9.12008-03-0145PRE
Nerve growth factor sequestering therapy attenuates non-malignant skeletal pain following fracturePAINIF5.52007-12-01102PRE
Endogenous opioids inhibit early-stage pancreatic pain in a mouse model of pancreatic cancerGASTROENTEROLOGYIF25.12006-09-0160OA